These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 8847894)
1. Sensitivity to dexamethasone and absence of bcl-2 protein in Burkitt's lymphoma cell line (Black93) derived from a patient with acute tumor lysis syndrome: comparative study with other BL and non-BL lines. Tani A; Tatsumi E; Nakamura F; Kumagai S; Kosaka Y; Sano K; Nakamura H; Amakawa R; Ohno H Leukemia; 1996 Oct; 10(10):1592-603. PubMed ID: 8847894 [TBL] [Abstract][Full Text] [Related]
2. Diverse properties of human t(8;14) neoplasms: [1] ATLS and absence of BCL-2 [2] modulation of RAG-1 expression with S-Ig ligation. Tani A; Tatsumi E; Nakamura F; Kumagai S Hum Cell; 1996 Dec; 9(4):337-44. PubMed ID: 9183667 [TBL] [Abstract][Full Text] [Related]
3. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines. Röth A; Pfaff P; Lange W; Finke J Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686 [TBL] [Abstract][Full Text] [Related]
4. Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis. Gutiérrez MI; Cherney B; Hussain A; Mostowski H; Tosato G; Magrath I; Bhatia K Cancer Res; 1999 Feb; 59(3):696-703. PubMed ID: 9973220 [TBL] [Abstract][Full Text] [Related]
5. Human B-lymphoid cell lines. Nilsson K Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931 [TBL] [Abstract][Full Text] [Related]
6. B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation. Cohen JH; Revillard JP; Magaud JP; Lenoir G; Vuillaume M; Manel AM; Vincent C; Bryon PA J Natl Cancer Inst; 1987 Feb; 78(2):235-42. PubMed ID: 3027441 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus (EBV) and human hematopoietic cell lines: a review. Tatsumi E Hum Cell; 1992 Mar; 5(1):79-86. PubMed ID: 1329932 [TBL] [Abstract][Full Text] [Related]
8. Expression of interleukin 10 in B lymphocytes of different origin. Finke J; Ternes P; Lange W; Mertelsmann R; Dölken G Leukemia; 1993 Nov; 7(11):1852-7. PubMed ID: 7694007 [TBL] [Abstract][Full Text] [Related]
10. Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1. Denyssevych T; Lestou VS; Knesevich S; Robichaud M; Salski C; Tan R; Gascoyne RD; Horsman DE; Mayer LD Leukemia; 2002 Feb; 16(2):276-83. PubMed ID: 11840295 [TBL] [Abstract][Full Text] [Related]
11. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines. Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047 [TBL] [Abstract][Full Text] [Related]
12. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines. Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341 [TBL] [Abstract][Full Text] [Related]
13. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition. Griffin H; Rowe M; Murray R; Brooks J; Rickinson A Eur J Immunol; 1992 Jul; 22(7):1741-8. PubMed ID: 1378014 [TBL] [Abstract][Full Text] [Related]
14. Role of bcl-2 in Epstein-Barr virus-induced malignant conversion of Burkitt's lymphoma cell line Akata. Komano J; Takada K J Virol; 2001 Feb; 75(3):1561-4. PubMed ID: 11152530 [TBL] [Abstract][Full Text] [Related]
15. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression. Wolf J; Pawlita M; Bullerdiek J; zur Hausen H Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373 [TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma. Rooney CM; Rickinson AB; Moss DJ; Lenoir GM; Epstein MA IARC Sci Publ; 1985; (60):249-64. PubMed ID: 2998992 [TBL] [Abstract][Full Text] [Related]
17. Reduced signal transduction through glucocorticoid receptor in Burkitt's lymphoma cell lines. Sinclair AJ; Jacquemin MG; Brooks L; Shanahan F; Brimmell M; Rowe M; Farrell PJ Virology; 1994 Mar; 199(2):339-53. PubMed ID: 8122366 [TBL] [Abstract][Full Text] [Related]
18. Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines. Chaouchi N; Arvanitakis L; Auffredou MT; Blanchard DA; Vazquez A; Sharma S Oncogene; 1995 Oct; 11(8):1615-22. PubMed ID: 7478586 [TBL] [Abstract][Full Text] [Related]
19. Cytokine signatures of transformed B cells with distinct Epstein-Barr virus latencies as a potential diagnostic tool for B cell lymphoma. Miyauchi K; Urano E; Yoshiyama H; Komano J Cancer Sci; 2011 Jun; 102(6):1236-41. PubMed ID: 21392167 [TBL] [Abstract][Full Text] [Related]
20. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells. Barnouin K; Fredersdorf S; Eddaoudi A; Mittnacht S; Pan LX; Du MQ; Lu X Oncogene; 1999 Nov; 18(46):6388-97. PubMed ID: 10597239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]